Results for Medical devices:
Department: Lecturer, Trust Center for MIT Entrepreneurship
Contact: (408) 888-5811, ccalarco@mit.edu
Department: Senior Lecturer, Trust Center for MIT Entrepreneurship
Contact: (617) 357-7474, jfleming@oxbio.com
Expertise: $100K Entrepreneurship Competition; Alliances; Analysts forecasts; Angel investing; Applied economics; Biopharmaceutical; Biotechnology; Business plans; Cancer, multi-drug therapy models; Capital budgeting; Capital market; CEO compensation; Corporate diversification; Corporate finance; Corporate governance; Economic history; Economics; Economics of organizations; Emerging businesses; Entrepreneurial finance; Entrepreneurship / New ventures; Euro; Federal Reserve; Finance; Financial engineering; Financial reporting; Foreign investment; Genetics; Germany; Health management; Healthcare industry; Hedge funds; HIV, multi-drug therapy models; Industrial economics; Investment analysis; Knowledge management; Medical devices; Medicine; Mergers and acquisitions; Microeconomics; Middle East; New ventures; Patents; Political economy; Research and development; Sarbanes-Oxley compliance; Startups; Technological innovation; Venture capital
T. Wilson (1953) Professor in Management
Department: Professor of Management of Innovation and Engineering Systems
Contact: (617) 253-7155, evhippel@mit.edu
Expertise: Change management; High technology companies; Innovation; Lead users; Management of technology; Managing change; Medical devices; Open source software; Patents; Research and development; Technological innovation; Technology strategy; Technology transfer
Department: Lecturer, Martin Trust Center for MIT Entrepreneurship
Contact: (781) 684-0239, azarur@mit.edu
Expertise: Biopharmaceutical; Biotechnology; Business plans; Climate policy; Clinical trials; Drug and biological regulatory strategies; Drug models; Emerging businesses; Energy; Entrepreneurial management; Entrepreneurship / New ventures; Environment; Global climate change; Global warming; Healthcare; Innovation; Medical devices; Mexico; New ventures; Pharmaceutical; Research and development; Startup; Venture capital